Heritage Cannabis announces the launch of the first medical product Opticann CB4 in Canada and the Canadian product website Opticann.ca

0


TORONTO – (COMMERCIAL THREAD) – Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce that Opticann, the medical brand and subsidiary of Heritage, is launching its first suite of CB4 brand products and launched Opticann.ca in Canada. Supported by evidence, CB4 products allow Heritage to develop a larger medical market with CB4 branded products offered on multiple medical platforms in Canada.

Opticann medical cannabis products merge cannabis medicine with modern medicine. The products take advantage of pharmaceutical technology to maximize performance and safety. CB4 products are formulated based on the latest medical evidence and come in convenient dosage forms that provide effective levels of cannabinoids.

The CB4 product launch initially includes Opticann’s CB4 Relief-T 25 mg capsules formulated with VESIsorb® technology, CB4 Relief 0.5% Deep Rub gel formulated with enhanced skin permeation technology for maximum effect, and CB4 Control CBD and CBDA 10 mg film strips based on Versafilm® Technology for rapid and maximum absorption of the sublingual cavity.

Additional CB4 products from the Opticann branded product line will be launched in the coming weeks, including CB4 Derma skin cream and CB4 Clear skin care products for the face, uniquely backed by data from ” product-specific clinical trials. CB4 Relief, the THC-free CBD softgels formulated with VESIsorb® technology will be available in early November.

“Heritage believes in improving the lives of many people with chronic illnesses through our quality, well-thought-out, evidence-based medical cannabis products that take advantage of innovative pharmaceutical technology. We believe that all patients who could benefit from our products should have access to them, which is why we offer CB4 products on several medical cannabis platforms in Canada, ”said Umar Syed, president of the medical division of Heritage. “We are delighted to introduce to Canada our revolutionary line of CB4 medical products which are supported by objective scientific data that attest to their superior performance and come in convenient dosage forms familiar to most medical patients – oral, topical and sublingual. ”

About Heritage Cannabis Holdings Corp.

Heritage is a leading cannabis products company operating two licensed manufacturing facilities in Canada and delivering innovative products to the legal medical and recreational cannabis markets in Canada and the United States. The company has an extensive portfolio of high quality cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, feelgood, product suite CB4 and ArthroCBD (in the US).

The Canadian Securities Exchange accepts no responsibility for the adequacy or accuracy of this release.


Share.

About Author

Leave A Reply